Exel Way Pharma is a Portuguese based cannabis company focused on industrial cultivation and production of medical grade cannabis (MGC) products and derivatives (i.e. cannabinoids, terpenes, etc.) in a wide range of levels and values.
Principal markets include the European Union and other continental European countries such as Switzerland, the United Kingdom, and Norway.
Transformative investment designed to create a player ripe for acquisition by a strategic.
Steven M. Pepa, Director → bio
Dr. Oded Sagee, Chief Science Officer → bio